ALNY vs PRTA · P/E 76, rev $1.29B vs rev $1.0M
Alnylam Pharmaceuticals Inc (ALNY) versus Prothena Corporation plc (PRTA) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Prothena Corporation plc (PRTA) is a biotechnology company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported PRTA revenue for 2026-06-30 was $1.0M. Net income was -$18.6M. Revenue was down 98.0% from 2026-03-31 to 2026-06-30. PRTA currently screens at market cap $460.2M.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. PRTA currently screens at market cap $460.2M.
Not investment advice. Open the ALNY and PRTA stock pages for the full models.
Not investment advice.